Taipei: A research team at Taipei Veterans General Hospital (TVGH) has made a significant breakthrough in migraine research. They have discovered that specific concentrations of microRNAs (miRNAs) in the blood can determine migraine risk and disease status with an accuracy rate exceeding 90 percent. This development was announced during a press conference held in Taipei on Monday.

According to Focus Taiwan, this study is among the few globally that have successfully identified biomarkers during a migraine attack. Migraine is one of the most prevalent neurological disorders worldwide, with a prevalence rate of up to 15 percent, as explained by TVGH Deputy Superintendent Wang Shuu-jiun. Wang, who also serves as the dean of the College of Medicine at National Yang Ming Chiao Tung University, highlighted that over one billion people suffer from migraines globally, including nearly two million in Taiwan.

During the press conference, Wang emphasized the study's findings, which revealed that migraine is the second leading cause of disability among individuals aged 15 to 49. This condition severely affects work, education, and overall quality of life. Additionally, women are three times more likely than men to experience migraines, Wang noted.